United States · FDA National Drug Code directory
Buspirone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24689-933_19f3df29-51b2-7f8b-e063-6294a90a542f
- Product NDC
- 24689-933
- Form
- TABLET
- Composition / generic term
- Buspirone Hydrochloride
- Labeler
- APNAR PHARMA LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240617
- Source listing expiry
- 20261231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (24689-933-06) · 24689-933-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →